Investigation of Sulindac in Male Fragile X Syndrome Patients Aged 13-40
A Phase IIa, Double-blind, Placebo-controlled Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HX02_01) Alone and Subsequently in Combination With Other Drugs in Adolescent and Adult Males With Fragile X Syndrome (FXS) A Phase IIa, Double-blind, Placebo-controlled Adaptive Design Study to Explore the Safety and Effica ...